Adaptyv

Adaptyv Bio runs an automated lab that experimentally validates protein designs. Customers upload protein sequences through a web portal or API, choose an assay (expression, binding affinity via BLI and SPR, or thermostability), and receive results and clean, labelled data packages. The website lists per-protein pricing from $49 for expression and $99 for binding and thermostability, with standard delivery in 2-4 weeks.

The company describes its customers as protein engineers and protein design teams, including teams that use generative AI to design proteins. Revenue comes from per-protein assay orders. The website also mentions a $40M Series A announced in August 2026, and lists angel investors. The founders are CEO Julian Englert and CTO Daniel Nakhaee-Zadeh.

The team page and job listings show offices in Lausanne, Switzerland and London, UK. The company is hiring across molecular biology, lab automation, software engineering, operations and sales, with most open roles in Lausanne and London.

Product: Protein validation service: expression, binding (BLI/SPR) and thermostability assays on a web platform with API access and experiment data packages.